Advantage, 100 mg/ml täpilahus kassidele
Advantage, 100 mg/ml täpilahus kassidele
Authorised
- Imidacloprid
Product identification
Medicine name:
Advantage, 100 mg/ml täpilahus kassidele
Active substance:
- Imidacloprid
Target species:
-
Cat
Route of administration:
-
Spot-on use
Product details
Active substance and strength:
-
Imidacloprid80.00/milligram(s)1.00Tube
Pharmaceutical form:
-
Spot-on solution
Withdrawal period by route of administration:
-
Spot-on use
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AX17
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Available in:
-
Estonia
Package description:
- Available only in Estonian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 2330
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 20/02/2024
How useful was this page?:
